Related Experiment Video
Updated: Aug 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction
Myungsoo Joo1, Young S Hahn, Minjae Kwon
1Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2650, USA. myungsoo.joo@vanderbilt.edu
Insights
Hepatitis C virus (HCV) core protein disrupts immune cell function by inhibiting NF-kappaB activation and cyclooxygenase-2 (COX-2) expression in macrophages, potentially impacting HCV pathogenesis.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infects hepatocytes and immune cells like macrophages.
- The impact of HCV on macrophage function is not well understood.
- Lipopolysaccharide (LPS) activates the IKK/NF-kappaB pathway, inducing cyclooxygenase-2 (COX-2) and prostaglandin production, key inflammatory mediators.
Purpose of the Study:
- To investigate if HCV core protein interferes with IKK signalsome activity and COX-2 expression in activated macrophages.
- To elucidate the molecular mechanisms by which HCV might modulate immune responses in macrophages.
Main Methods:
- Reporter assays in RAW 264.7 and MH-S murine macrophage cell lines treated with LPS.
- Analysis of IKK signalsome and IKKbeta kinase activities in HeLa and 293 cells.
- Co-precipitation assays to assess interactions between HCV core and IKKbeta.
- Western blotting to evaluate COX-2 expression levels.
Main Results:
- HCV core inhibited NF-kappaB activation induced by LPS in macrophage cell lines.
- HCV core suppressed IKK signalsome and IKKbeta kinase activities.
- HCV core interacted with IKKbeta and prevented its nuclear translocation.
- Ectopic expression of HCV core markedly suppressed LPS- or IKKbeta-induced COX-2 expression.
Conclusions:
- HCV core protein suppresses IKK signalsome activity in macrophages.
- This suppression leads to blunted COX-2 expression, potentially affecting inflammatory responses.
- Further research is needed to determine the role of disrupted COX-2 expression in HCV pathogenesis.
Abstract:
In addition to hepatocytes, hepatitis C virus (HCV) infects immune cells, including macrophages. However, little is known concerning the impact of HCV infection on cellular functions of these immune effector cells. Lipopolysaccharide (LPS) activates IkappaB kinase (IKK) signalsome and NF-kappaB, which leads to the expression of cyclooxygenase-2 (COX-2), which catalyzes production of prostaglandins, potent effectors on inflammation and possibly hepatitis. Here, we examined whether expression of HCV core interferes with IKK signalsome activity and COX-2 expression in activated macrophages. In reporter assays, HCV core inhibited NF-kappaB activation in RAW 264.7 and MH-S murine macrophage cell lines treated with bacterial LPS. HCV core inhibited IKK signalsome and IKKbeta kinase activities induced by tumor necrosis factor alpha in HeLa cells and coexpressed IKKgamma in 293 cells, respectively. HCV core was coprecipitated with IKappaKappabeta and prevented nuclear translocation of IKKbeta. NF-kappaB activation by either LPS or overexpression of IKKbeta was sufficient to induce robust expression of COX-2, which was markedly suppressed by ectopic expression of HCV core. Together, these data indicate that HCV core suppresses IKK signalsome activity, which blunts COX-2 expression in macrophages. Additional studies are necessary to determine whether interrupted COX-2 expression by HCV core contributes to HCV pathogenesis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Co-activators and Co-repressors
Co-activators and Co-repressors

